|1||Active, not recruiting||
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
Genetic Response to Warfarin in Healthy Subjects
Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome
† Study has passed its completion date and status has not been verified in more than two years.